Seminars in Hematology
Volume 40, Issue 3 , Pages 175-184 , July 2003

Classification of cytotoxic T-cell and natural killer cell lymphomas

  • Elaine S. Jaffe

      Affiliations

    • *Address correspondence to Elaine S. Jaffe, MD, Laboratory of Pathology, NCI, Building 10/Room 2N202, 10 Center Dr, MSC-1500, Bethesda, MD 20892-1500, USA
    • Hematopathology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA
    • ,
  • Laszlo Krenacs

      Affiliations

    • Laboratory of Tumor Pathology and Molecular Diagnostics, Institute of Biotechnology, Bay Zoltan Foundation for Applied Research, Szeged, Hungary
    • ,
  • Mark Raffeld

      Affiliations

    • Hematopathology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA

References 

  1. The Non-Hodgkin’s Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin’s lymphoma. Blood. 1997;89:3909–3918
  2. Alonsozana EL, Stamberg J, Kumar D, et al.  Isochromosome 7q: The primary cytogenetic abnormality in hepatosplenic gamma delta T cell lymphoma. Leukemia. 1997;11:11172–11367
  3. Anderson JR, Armitage JO, Weisenburger DD. Epidemiology of the non-Hodgkin’s lymphomas: Distributions of the major subtypes differ by geographic locations. Non-Hodgkin’s Lymphoma Classification Project. Ann Oncol. 1998;9:717–720
  4. Arber DA, Weiss LM, Albujar PF, et al.  Nasal lymphomas in Peru. High incidence of T-cell immunophenotype and Epstein-Barr virus infection. Am J Surg Pathol. 1993;17:392–399
  5. Arnulf B, Copie-Bergman C, Delfau-Larue MH, et al.  Nonhepatosplenic gamma-delta T-cell lymphoma: A subset of cytotoxic lymphomas with mucosal or skin localization. Blood. 1998;91:1723–1731
  6. Ashkenazi A, Dixit VM. Apoptosis control by death and decoy receptors. Curr Opin Cell Biol. 1999;11:255–260
  7. Bagdi E, Diss TC, Munson P, et al.  Mucosal intra-epithelial lymphocytes in enteropathy-associated T-cell lymphoma, ulcerative jejunitis, and refractory celiac disease constitute a neoplastic population. Blood. 1999;94:260–264
  8. Berti E, Cerri A, Cavicchini S, et al.  Primary cutaneous gamma/delta T-cell lymphoma presenting as disseminated pagetoid reticulosis. J Invest Dermatol. 1991;96:718–723
  9. Berti E, Tomasini D, Vermeer MH, et al.  Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior. Am J Pathol. 1999;155:483–492
  10. Burg G, Dummer R, Wilhelm M, et al.  A subcutaneous delta-positive T-cell lymphoma that produces interferon gamma. N Engl J Med. 1991;325:1078–1081
  11. Cellier C, Delabesse E, Helmer C, et al.  Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group. Lancet. 2000;356:203–208
  12. Chan J, Ng C, Lau W, et al.  Most nasal/nasopharyngeal lymphomas are peripheral T cell neoplasms. Am J Surg Pathol. 1987;11:418–429
  13. Chan JK. Natural killer cell neoplasms. Anat Pathol. 1998;3:77–145
  14. Chan JKC, Ng CS, Ngan KC, et al.  Angiocentric T-cell lymphoma of the skin. An aggressive lymphoma distinct from mycosis fungoides. Am J Surg Pathol. 1988;12:861–876
  15. Chan JKC, Sin VC, Wong KF, et al.  Nonnasal lymphoma expressing the natural killer cell marker CD56: A clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood. 1997;89:4501–4513
  16. Charton-Bain MC, Brousset P, Bouabdallah R, et al.  Variation in the histological pattern of nodal involvement by gamma/delta T-cell lymphoma. Histopathology. 2000;36:233–239
  17. Chott A, Dragosics B, Radaszkiewicz T. Peripheral T-cell lymphomas of the intestine. Am J Pathol. 1992;141:1361–1371
  18. Chott A, Haedicke W, Mosberger I, et al.  Most CD56+ intestinal lymphomas are CD8+CD5- T-cell lymphomas of monomorphic small to medium size histology. Am J Pathol. 1998;153:1483–1490
  19. Cooke CB, Krenacs M, Stetler-Stevenson M, et al.  Hepatosplenic gamma/delta T-cell lymphoma: A distinct clinicopathologic entity of cytotoxic gamma/delta T-cell origin. Blood. 1996;88:4265–4274
  20. de Bruin PC, Jiwa M, Oudejans JJ, et al.  Presence of Epstein-Barr virus in extranodal T-cell lymphomas: Differences in relation to site. Blood. 1994;83:1612–1618
  21. de Bruin PC, Kummer JA, van der Valk P, et al.  Granzyme B-expressing peripheral T-cell lymphomas: Neoplastic equivalents of activated cytotoxic T cells with preference for mucosa-associated lymphoid tissue localization. Blood. 1994;84:3785–3791
  22. Delves PJ, Roitt IM. The immune system. First of two parts. N Engl J Med. 2000;343:37–49
  23. DeRemee RA, Weiland LH, McDonald TJ. Polymorphic reticulosis, lymphomatoid granulomatosis. Two diseases or one?. Mayo Clin Proc. 1978;53:634–640
  24. Dictor M, Cervin A, Kalm O, et al.  Sinonasal T-cell lymphoma in the differential diagnosis of lethal midline granuloma using in situ hybridization for Epstein-Barr viru RNA. Mod Pathol. 1996;9:7–14
  25. Elenitoba-Johnson KSJ, Zarate-Osorno A, Meneses A, et al.  Cytotoxic granular protein expression, Epstein-Barr virus strain type, and latent membrane protein-1 oncogene deletions in nasal T-lymphocyte/natural killer cell lymphomas from Mexico. Mod Pathol. 1998;11:754–761
  26. Farcet J, Gaulard P, Marolleau J, et al.  Hepatosplenic T-cell lymphoma: Sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor γδ. Blood. 1990;75:2213–2219
  27. Felgar RE, Macon WR, Kinney MC, et al.  TIA-1 expression in lymphoid neoplasms. Identification of subsets with cytotoxic T lymphocyte or natural killer cell differentiation. Am J Pathol. 1997;150:1893–1900
  28. Foss HD, Anagnostopoulos I, Araujo I, et al.  Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules. Blood. 1996;88:4005–4011
  29. Gallamini A, Carbone A, Lista P, et al.  Intestinal T-cell lymphoma with massive tissue and blood eosinophilia mediated by IL-5. Leuk Lymphoma. 1995;17:155–161
  30. Gaulard P, Bourquelot P, Kanavaros P, et al.  Expression of the alpha/beta and gamma/delta T-cell receptors in 57 cases of peripheral T-cell lymphomas. Identification of a subset of gamma/delta T-cell lymphomas. Am J Pathol. 1990;137:617–628
  31. Gaulard P, Zafrani ES, Mavier P, et al.  Peripheral T-cell lymphoma presenting as predominant liver disease: A report of three cases. Hepatology. 1986;6:864–868
  32. Gonzalez CL, Medeiros LJ, Braziel RM, et al.  T-cell lymphoma involving subcutaneous tissue: A clinicopathologic entity commonly associated with hemophagocytic syndrome. Am J Surg Pathol. 1991;15:17–27
  33. Greiner TC, Raffeld M, Lutz C, et al.  Analysis of T cell receptor-gamma gene rearrangements by denaturing gradient gel electrophoresis of GC-clamped polymerase chain reaction products. Correlation with tumor-specific sequences. Am J Pathol. 1995;146:46–55
  34. Gronbaek K, Straten P, Ralfkiaer E, et al.  Somatic fas mutations in non-Hodgkin’s lymphoma: Association with extranodal disease and autoimmunity. Blood. 1998;92:3018–3024
  35. Guinee DJ, Jaffe E, Kingma D, et al.  Pulmonary lymphomatoid granulomatosis. Evidence for a proliferation of Epstein-Barr virus infected B-lymphocytes with a prominent T-cell component and vasculitis. Am J Surg Pathol. 1994;18:753–764
  36. Ho F, Choy D, Loke S, et al.  Polymorphic reticulosis and conventional lymphomas of the nose and upper aerodigestive tract—A clinicopathologic study of 70 cases, and immunophenotypic studies of 16 cases. Hum Pathol. 1990;21:1041–1050
  37. Ho F, Srivastava G, Loke S, et al.  Presence of Epstein-Barr virus DNA in nasal lymphomas of B and T cell type. Hematol Oncol. 1990;8:271–281
  38. Holmes GK. Coeliac disease and malignancy. Dig Liver Dis. 2002;34:229–237
  39. Hussell T, Isaacson PG, Crabtree JE, et al.  Helicobacter pylori-specific tumour-infiltrating T cells provide contact dependent help for the growth of malignant B cells in low-grade gastric lymphoma of mucosa-associated lymphoid tissue. J Pathol. 1996;178:122–127
  40. Imamura N, Kusunoki Y, Kawa-Ha K, et al.  Aggressive natural killer cell leukaemia/lymphoma: Report of four cases and review of the literature. Possible existence of a new clinical entity originating from the third lineage of lymphoid cells. Br J Haematol. 1990;75:49–59
  41. Isaacson P, Spencer J, Connolly C, et al.  Malignant histiocytosis of the intestine: A T-cell lymphoma. Lancet. 1985;2:688–691
  42. Isaacson P, Wright D. Malignant histiocytosis of the intestine: Its relationship to malabsorption and ulcerative jejeunitis. Hum Pathol. 1978;9:661–677
  43. Jaffe ES. Classification of NK-cell and NK-like T-cell malignancies. (editorial) Blood. 1996;87:1207–1210
  44. Jaffe ES. Anaplastic large cell lymphoma: The shifting sands of diagnostic hematopathology. Mod Pathol. 2001;14:219–228
  45. Jaffe ES, Chan JKC, Su IJ, et al.  Report of the workshop on nasal and related extranodal angiocentric T/NK cell lymphomas: Definitions, differential diagnosis, and epidemiology. Am J Surg Pathol. 1996;20:103–111
  46. Jaffe ES, Costa J, Fauci AS, et al.  Malignant lymphoma and erythrophagocytosis simulating malignant histiocytosis. Am J Med. 1983;75:741–749
  47. Jaffe ES, Harris NL, Stein H, et al.  Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumours. Lyon, France: IARC Press,; 2001;
  48. Jaffe ES, Krenacs L, Kumar S, et al.  Extranodal peripheral T-cell and NK-cell neoplasms. Am J Clin Pathol. 1999;111:S46–S55
  49. Jaffe ES, Wilson WH. Lymphomatoid granulomatosis: Pathogenesis, pathology, and clinical implications. Cancer Surv. 1997;30:233–248
  50. Jones D, O’Hara C, Kraus MD, et al.  Expression pattern of T-cell-associated chemokine receptors and their chemokines correlates with specific subtypes of T-cell non-Hodgkin lymphoma. Blood. 2000;96:685–690
  51. Kanavaros P, Boulland ML, Petit B, et al.  Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: Association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression. Leuk Lymphoma. 2000;38:317–326
  52. Kanavaros P, De Bruin PC, Briere J, et al.  Epstein-Barr virus (EBV) in extranodal T-cell non-Hodgkin’s lymphomas (T-NHL). Identification of nasal T-NHL as a distinct clinicopathological entity associated with EBV. Leuk Lymphoma. 1995;18:27–34
  53. Kanegane H, Bhatia K, Gutierrez M, et al.  A syndrome of peripheral blood T-cell infection with Epstein-Barr virus (EBV) followed by EBV-positive T-cell lymphoma. Blood. 1998;91:2085–2091
  54. Katzenstein A-L, Peiper S. Detection Epstein-Barr genomes in lymphomatoid granulomatosis: Analysis of 29 cases by the polymerase chain reaction. Mod Pathol. 1990;3:435–441
  55. Katzenstein AA, Carrington CB, Liebow AA. Lymphomatoid granulomatosis: A clinicopathologic study of 152 cases. Cancer. 1979;43:360–373
  56. Kikuta H, Sakiyama Y, Matsumoto S, et al.  Fatal Epstein-Barr virus-associated hemophagocytic syndrome. Blood. 1993;82:3259–3264
  57. Kluin PM, Feller A, Gaulard P, et al.  Peripheral T/NK-cell lymphoma: A report of the IXth Workshop of the European Association for Haematopathology Conference report. Histopathology. 2001;38:250–270
  58. Krafft AE, Taubenberger JK, Sheng ZM, et al.  Enhanced sensitivity with a novel TCRgamma PCR assay for clonality studies in 569 formalin-fixed, paraffin-embedded (FFPE) cases. Mol Diagn. 1999;4:119–133
  59. Krenacs L, Smyth MJ, Bagdi E, et al.  The serine protease granzyme M is preferentially expressed in NK-cell, gd T-cell, and intestinal T-cell lymphomas, suggesting that these tumors may arise from lymphocytes involved in innate immunity. Blood. 2003;101:3590–3593
  60. Krenacs L, Wellmann A, Sorbara L, et al.  Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and null-cell type and Hodgkin’s disease: Evidence for distinct cellular origin. Blood. 1997;89:980–989
  61. Kumar S, Krenacs L, Elenitoba-Johnson K, et al.  Subcutaneous panniculitic T-cell lymphoma is a tumor of cytotoxic T-lymphocytes. Hum Pathol. 1998;29:397–403
  62. Kumar S, Lawlor C, Jaffe ES. Hepatosplenic T-cell lymphoma of alpha-beta lineage. Am J Surg Pathol. 2001;25:970–971
  63. Lamy T, Liu JH, Landowski TH, et al.  Dysregulation of CD95/CD95 ligand-apoptotic pathway in CD3(+) large granular lymphocyte leukemia. Blood. 1998;92:4771–4777
  64. Lavergne A, Brocheriou I, Delfau MH, et al.  Primary intestinal gamma-delta T-cell lymphoma with evidence of Epstein-Barr virus. Histopathology. 1998;32:271–276
  65. Lay JD, Tsao CJ, Chen JY, et al.  Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome. J Clin Invest. 1997;100:1969–1979
  66. Liang R. Diagnosis and management of primary nasal lymphoma of T-cell or NK-cell origin. Clin Lymphoma. 2000;1:33–37
  67. Lipford EH, Margolick JB, Longo DL, et al.  Angiocentric immunoproliferative lesions: A clinicopathologic spectrum of post-thymic T cell proliferations. Blood. 1988;5:1674–1681
  68. Liu CC, Young LH, Young JD. Lymphocyte-mediated cytolysis and disease. N Engl J Med. 1996;335:1651–1659
  69. Lundin KE, Scott H, Hansen T, et al.  Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med. 1993;178:187–196
  70. Macon WR, Levy NB, Kurtin PJ, et al.  Hepatosplenic alphabeta T-cell lymphomas: A report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas. Am J Surg Pathol. 2001;25:285–296
  71. Medeiros LJ, Jaffe ES, Chen YY, et al.  Localization of Epstein-Barr viral genomes in angiocentric immunoproliferative lesions. Am J Surg Pathol. 1992;16:439–447
  72. Medeiros LJ, Peiper SC, Elwood L, et al.  Angiocentric immunoproliferative lesions: A molecular analysis of eight cases. Hum Pathol. 1991;22:1150–1157
  73. Monsalve MV, Helgason A, Devine DV. Languages, geography and HLA haplotypes in native American and Asian populations. Proc R Soc London B. 1999;266:2209–2216
  74. Munn SE, McGregor JM, Jones A, et al.  Clinical and pathological heterogeneity in cutaneous gamma-delta T-cell lymphoma: A report of three cases and a review of the literature. Br J Dermatol. 1996;135:976–981
  75. Ng CS, Lo ST, Chan JK. Peripheral T and putative natural killer cell lymphomas commonly coexpress CD95 and CD95 ligand. Hum Pathol. 1999;30:48–53
  76. Ohshima K, Suzumiya J, Shimazaki K, et al.  Nasal T/NK cell lymphomas commonly express perforin and Fas ligand: Important mediators of tissue damage. Histopathology. 1997;31:444–450
  77. Patey-Mariaud De Serre N, Cellier C, Jabri B, et al.  Distinction between coeliac disease and refractory sprue: A simple immunohistochemical method. Histopathology. 2000;37:70–77
  78. Picker L, Weiss L, Medeiros L, et al.  Immunophenotypic criteria for the diagnosis of non-Hodgkin’s lymphma. Am J Pathol. 1987;128:181–201
  79. Quintanilla-Martinez L, Franklin JL, Guerrero I, et al.  Histological and immunophenotypic profile of nasal NK/T cell lymphomas from Peru: High prevalence of p53 overexpression. Hum Pathol. 1999;30:849–855
  80. Quintanilla-Martinez L, Kumar S, Fend F, et al.  Fulminant EBV(+) T-cell lymphoproliferative disorder following acute/chronic EBV infection: A distinct clinicopathologic syndrome. Blood. 2000;96:443–451
  81. Quintanilla-Martinez L, Lome-Maldonado C, Ott G, et al.  Primary intestinal non-Hodgkin’s lymphoma and Epstein-Barr virus: High frequency of EBV-infection in T-cell lymphomas of Mexican origin. Leuk Lymphoma. 1998;30:111–121
  82. Ralfkiaer E, Wollf-Sneedorff A, Thomsen K, et al.  T-cell receptor gamma delta-positive peripheral T-cell lymphomas presenting in the skin: A clinical, histological and immunophenotypic study. Exp Dermatol. 1992;1:31–36
  83. Regnault A, Levraud JP, Lim A, et al.  The expansion and selection of T cell receptor alpha beta intestinal intraepithelial T cell clones. Eur J Immunol. 1996;26:914–921
  84. Salhany KE, Macon WR, Choi JK, et al.  Subcutaneous panniculitis-like T-cell lymphoma: Clinicopathologic, immunophenotypic, and genotypic analysis of alpha/beta and gamma/delta subtypes. Am J Surg Pathol. 1998;22:881–893
  85. Sayers TJ, Brooks AD, Ward JM, et al.  The restricted expression of granzyme M in human lymphocytes. J Immunol. 2001;166:765–771
  86. Smyth MJ, Kelly JM, Sutton VR, et al.  Unlocking the secrets of cytotoxic granule proteins. J Leukoc Biol. 2001;70:18–29
  87. Smyth MJ, O’Connor MD, Kelly JM, et al.  Expression of recombinant human Met-ase-1: A NK cell-specific granzyme. Biochem Biophys Res Commun. 1995;217:675–683
  88. Smyth MJ, O’Connor MD, Trapani JA, et al.  A novel substrate-binding pocket interaction restricts the specificity of the human NK cell-specific serine protease, Met-ase-1. J Immunol. 1996;156:4174–4181
  89. Spencer J, Cerf-Bensussan N, Jarry A, et al.  Enteropathy-associated T-cell lymphoma is recognized by a monoclonal antibody (HML-1) that defines a membrane molecule on human mucosal lymphocytes. Am J Pathol. 1988;132:1–5
  90. Spencer J, Isaacson PG, MacDonald TT, et al.  Gamma/delta T cells and the diagnosis of coeliac disease. Clin Exp Immunol. 1991;85:109–113
  91. Stein H, Foss HD, Durkop H, et al.  CD30(+) anaplastic large cell lymphoma: A review of its histopathologic, genetic, and clinical features. Blood. 2000;96:3681–3695
  92. Straus SE, Jaffe ES, Puck JM, et al.  The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood. 2001;98:194–200
  93. Su IJ, Hsieh HC, Lin KH, et al.  Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: A clinicopathologic and molecular analysis. Blood. 1991;77:799–808
  94. Su IJ, Lin DT, Hsieh HC, et al.  Fatal primary Epstein-Barr virus infection masquerading as histiocytic medullary reticulosis in young children in Taiwan. Hematol Pathol. 1990;4:189–195
  95. Suarez F, Wlodarska I, Rigal-Huguet F, et al.  Hepatosplenic alphabeta T-cell lymphoma: An unusual case with clinical, histologic, and cytogenetic features of gammadelta hepatosplenic T-cell lymphoma. Am J Surg Pathol. 2000;24:1027–1032
  96. Tazawa Y, Nishinomiya F, Noguchi H, et al.  A case of fatal infectious mononucleosis presenting with fulminant hepatic failure associated with an extensive CD8-positive lymphocyte infiltration in the liver. Hum Pathol. 1993;24:1135–1139
  97. Teruya-Feldstein J, Jaffe ES, Burd PR, et al.  The role of Mig, the monokine induced by interferon-gamma, and IP-10, the interferon-gamma-inducible protein-10, in tissue necrosis and vascular damage associated with Epstein-Barr virus-positive lymphoproliferative disease. Blood. 1997;90:4099–5105
  98. Teruya-Feldstein J, Setsuda J, Yao X, et al.  MIP-1alpha expression in tissues from patients with hemophagocytic syndrome. Lab Invest. 1999;79:1583–1590
  99. Toro J, Liewehr DJ, Pabby N, et al.  Gamma delta T-cell phenotype is associated with significantly decreased survival in cutaneous-T-cell lymphoma. Blood. 2003;101:3407–3412
  100. Toro JR, Beaty M, Sorbara L, et al.  Gamma delta T-cell lymphoma of the skin: A clinical, microscopic, and molecular study. Arch Dermatol. 2000;136:1024–1032
  101. Tsang WY, Chan JK, Yip TT, et al.  In situ localization of Epstein-Barr virus encoded RNA in non-nasal/nasopharyngeal CD56-positive and CD56-negative T-cell lymphomas. Hum Pathol. 1994;25:758–765
  102. Van Camp B, Durie B, Spier C, et al.  Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56 (NHK-1; Leu-19). Blood. 1990;76:377–382
  103. van de Wal Y, Kooy YM, van Veelen PA, et al.  Small intestinal T cells of celiac disease patients recognize a natural pepsin fragment of gliadin. Proc Natl Acad Sci USA. 1998;95:10050–10054
  104. Walczak H, Krammer PH. The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems. Exp Cell Res. 2000;256:58–66
  105. Wang CC, Tien HF, Lin MT, et al.  Consistent presence of isochromosome 7q in hepatosplenic T gamma/delta lymphoma: A new cytogenetic-clinicopathologic entity. Genes Chromosomes Cancer. 1995;12:161–164
  106. Wilson WH, Kingma DW, Raffeld M, et al.  Association of lymphomatoid granulomatosis with Epstein-Barr viral infection of B lymphocytes and response to interferon-alpha 2b. Blood. 1996;87:4531–4537
  107. Winkelman R, Bowie E. Hemorrhagic diathesis associated with benign histiocytic cytophagic panniculitis and systemic histiocytosis. Arch Intern Med. 1980;140:1460–1463
  108. Wlodarska I, Martin-Garcia N, Achten R, et al.  Fluorescence in situ hybridization study of chromosome 7 aberrations in hepatosplenic T-cell lymphoma: Isochromosome 7q as a common abnormality accumulating in forms with features of cytologic progression. Genes Chromosomes Cancer. 2002;33:243–251
  109. Yamashita Y, Nakamura S, Kagami Y, et al.  Lennert’s lymphoma: A variant of cytotoxic T-cell lymphoma?. Am J Surg Pathol. 2000;24:1627–1633

PII: S0037-1963(03)00132-X

Seminars in Hematology
Volume 40, Issue 3 , Pages 175-184 , July 2003

Article Tools